HW201012 World ADC Europe Banners v3

Welcome to ADC Europe - Your Digital Edition

Maximising the Clinical Therapeutic Window of Antibody-drug Conjugates

 

Now in its 11th year, World ADC Europe prides itself in being the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates.

Since the last World ADC London in March of 2020, we have seen huge progress within the ADC field with the approval of Trodelvy from Immunomedics, Blenrep from GSK – and now with ADC Therapeutics submitting their BLA in September of 2020, could this be the next approved ADC?

Join fellow experts virtually across 140+ active organisations as they unite at this industry focussed digital conference to learn the latest ADC intelligence, foster new connections and develop business relationships with partners.

This year, you can be part of Europe’s longest standing and most comprehensive ADC conference from the comfort and safety of your workplace and continue to power the development of your ADC pipeline in 2021.

Complete Your 4-day World ADC Europe Digital Experience


Pre-Conference Seminar Day

.

Exploring in-depth the emerging areas of interest and hottest topics in the ADC field, take your pick from 3 pre-conference seminars, including:

  • 1st Non-Traditional ADC Day (NEW!)

A non-traditional ADC uses the exact same concept as an ADC in the sense that it is made up of three component that join together and the ‘payload’ provides the killing power. Join speakers from Bicycle Therapeutics, NBE Therapeutics and Genentech as we explore these novel concept ADCs.

  • 2nd CMC Day

Focussed from Phase II through to commercial scale manufacturing, the 2nd CMC Seminar Day will enable you to effectively scale up your manufacturing operation.

Enjoy a full day of presentations, roundtable sessions and panel discussions that highlight the biggest opportunities in the space and address their unique challenges.


2 Conference Days: 3 Tracks

.

 

Unlike being at a physical conference, if you would like to move between tracks, this is just a click away! No more running between rooms to make the next talk in time.

Providing you and your team with the full end-to-end drug development landscape, the two main summit days are divided across 3 comprehensive tracks of learning and delve into the following topics:

  1. Discovery
  2. Translational
  3. CMC 

Bring your team to divide and conquer, ensuring your whole company can benefit from the full range of world-class expertise being showcased from our 60 expert speakers.


Post-Conference Workshop Day
.
.

 

And finally, take those exciting discussions one step further by collaborating in an intimate environment with fellow ADC drug developers who are actively working on the same challenges as you.

Choose from 8 discussion-based, deep-dive workshops, including:

Application of Antibody-Drug Conjugates to Treat Difficult Tumours

The Chemistry of Toxins, Conjugations & Linkers for Antibody-drug Conjugates

Advanced ADC Target Discovery

Don’t miss the chance to ask your specific questions to the topic experts, and leave equipped with the technical knowledge required to bring an antibody drug conjugate to market.

HW201012 World ADC Europe Banners v42

About World ADC Series

The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.

Other Events In The Series

Proud to Partner With